Saxagliptin/Metformin Extended-Release (XR) for the Type 2 Diabetes (T2DM) Treatment in Venezuela: A Budget Impact Analysis
Value in Health - United Kingdom
doi 10.1016/j.jval.2014.03.1416
Full Text
Open PDFAbstract
Available in full text
Date
May 1, 2014
Authors
Publisher
Elsevier BV